These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34238472)
1. Disorders of hypothalamic function: Insights from Prader-Willi syndrome and the effects of craniopharyngioma. Whittington JE; Holland AJ Handb Clin Neurol; 2021; 181():381-389. PubMed ID: 34238472 [TBL] [Abstract][Full Text] [Related]
2. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. Goldstone AP; Patterson M; Kalingag N; Ghatei MA; Brynes AE; Bloom SR; Grossman AB; Korbonits M J Clin Endocrinol Metab; 2005 May; 90(5):2681-90. PubMed ID: 15687345 [TBL] [Abstract][Full Text] [Related]
3. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome. Correa-da-Silva F; Fliers E; Swaab DF; Yi CX J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126 [TBL] [Abstract][Full Text] [Related]
4. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review. Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467 [TBL] [Abstract][Full Text] [Related]
5. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. Whitman BY; Myers S; Carrel A; Allen D Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245 [TBL] [Abstract][Full Text] [Related]
6. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome. Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955 [TBL] [Abstract][Full Text] [Related]
7. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955 [TBL] [Abstract][Full Text] [Related]
8. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676 [TBL] [Abstract][Full Text] [Related]
9. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review. Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409 [TBL] [Abstract][Full Text] [Related]
10. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome. McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979 [TBL] [Abstract][Full Text] [Related]
14. Pituitary abnormalities in Prader-Willi syndrome and early onset morbid obesity. Miller JL; Goldstone AP; Couch JA; Shuster J; He G; Driscoll DJ; Liu Y; Schmalfuss IM Am J Med Genet A; 2008 Mar; 146A(5):570-7. PubMed ID: 17431897 [TBL] [Abstract][Full Text] [Related]
15. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Höybye C Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552 [TBL] [Abstract][Full Text] [Related]
16. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia. Kweh FA; Miller JL; Sulsona CR; Wasserfall C; Atkinson M; Shuster JJ; Goldstone AP; Driscoll DJ Am J Med Genet A; 2015 Jan; 167A(1):69-79. PubMed ID: 25355237 [TBL] [Abstract][Full Text] [Related]
17. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. Angulo MA; Butler MG; Cataletto ME J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517 [TBL] [Abstract][Full Text] [Related]
18. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765 [TBL] [Abstract][Full Text] [Related]
19. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337 [TBL] [Abstract][Full Text] [Related]
20. Hypothalamic obesity in children. Bereket A; Kiess W; Lustig RH; Muller HL; Goldstone AP; Weiss R; Yavuz Y; Hochberg Z Obes Rev; 2012 Sep; 13(9):780-98. PubMed ID: 22577758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]